Physician profile
Sameer Goel
NPI 1073044897
$10,724.21
in general payments reported to CMS, 2019-2025
16 companies · $1,580 in 2025
The $1,580 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,365 · 2022: $3,983 · 2023: $897 · 2024: $1,900 · 2025: $1,580.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,278 · Travel and Lodging: $1,098.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,277.90 |
| Travel and Lodging | $1,098.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $6,642.53 | 2021-2025 | Wavewriter Alpha Prime 16, Superion Indirect Decompression System |
| Medtronic, INC. | $1,218.21 | 2021-2025 | Kyphon Express II Kyphopak Tray, Intellis Adaptivestim, Vanta Adaptivestim |
| Si-Bone, INC. | $1,193.31 | 2025 | |
| Nevro Corp. | $410.22 | 2022-2024 | Senza |
| Saluda Medical Americas, INC. | $338.78 | 2023 | Evoke Scs |
| Abbott Laboratories | $298.84 | 2022-2024 | Eterna, Proclaim |
| Nalu Medical, INC. | $239.24 | 2021-2025 | Nalu Neurostimulation System |
| Avanos Medical | $114.80 | 2025 | Coolief Cooled Radiofrequency |
| Vertos Medical, INC. | $113.33 | 2023 | Mild Device Kit |
| Arbor Pharmaceuticals, INC. | $32.28 | 2021-2022 | |
| Biotronik Nro, INC. | $29.94 | 2025 | Prospera |
| Curonix LLC | $21.12 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Spr Therapeutics, INC | $20.28 | 2023 | Sprint Pns System |
| Averitas Pharma INC. | $19.97 | 2023 | Qutenza |
| Painteq LLC | $17.73 | 2023 | Painteq |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mml US, INC. | $13.63 | 2025 | Reactiv8 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sameer Goel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.